metreleptin
Selected indexed studies
- Metreleptin treatment of non-HIV lipodystrophy syndromes. (Presse Med, 2021) [PMID:34571177]
- ** (, 2024) [PMID:39652691]
- ** (, 2021) [PMID:40811586]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Metreleptin treatment of non-HIV lipodystrophy syndromes. (2021) pubmed
- PMID:39652691 (2024) pubmed
- PMID:40811586 (2021) pubmed
- Metreleptin: first global approval. (2013) pubmed
- Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives. (2015) pubmed
- PMID:38985915 (2024) pubmed
- Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy. (2015) pubmed
- Metreleptin (Myalept): a leptin analog for generalized lipodystrophy. (2015) pubmed
- Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy. (2023) pubmed
- Lipodystrophy Syndromes. (2016) pubmed